News & Events
- HyperBranch Receives CE Mark for NuSeal 30 Hernia Mesh Fixation Sealant
- Durham, NC, October 13, 2009
HyperBranch Medical Technology, Inc. announced today that it has received a CE Mark for its NuSeal 30 hernia mesh fixation sealant product. NuSeal 30 is used in hernia procedures to adhere the mesh. NuSeal 30 provides for secure mesh placement, minimizes pain caused by other fixation devices and gradually degrades as the body heals. The CE Mark for NuSeal 30 provides regulatory approval for the company to begin the registration process in countries outside the U.S.
Read the full press release...
- HyperBranch Receives CE Mark for NuSeal 100 Dural Sealant
- Durham, NC, July 21, 2009
HyperBranch Medical Technology, Inc. announced today that it has received a CE Mark for its NuSeal 100 dural sealant product. NuSeal 100 is used in cranial neurosurgical procedures where a water tight seal is required on the dura. NuSeal 100 is intended for direct application on the dural surfaces to provide a positive seal after suturing thereby minimizing risks associated with post-surgical CSF leaks. The CE Mark for NuSeal 100 provides regulatory approval for the company to begin sales in Europe and potentially other countries outside the U.S.
Read the full press release...
- BD Launches BD OcuSeal™ Liquid Ocular Bandage
- Waltham, MA, March 17, 2009
BD Medical – Ophthalmic Systems, a unit of BD (Becton, Dickinson and Company), announced today the European launch of BD OcuSeal™ Liquid Ocular Bandage, a fully synthetic protective barrier designed to provide comfort for post-surgical, post-traumatic, and non-traumatic ocular conditions. This product has European CE Mark approval, and BD intends to initiate registration in other countries including the United States.
Read the full press release...
- HyperBranch Medical Technology, Inc., Licenses OcuSeal™ Liquid Ocular Bandage
to BD
- Durham, NC, March 17, 2009
HyperBranch Medical Technology, Inc., announced today the licensing of the Company’s OcuSeal™ Liquid Ocular Bandage to BD. OcuSeal™ is a fully synthetic ocular bandage designed as a temporary protective barrier to provide comfort for post-surgical, post-traumatic, and non-traumatic ocular conditions. BD Medical – Ophthalmic Systems, a unit of BD, has an exclusive worldwide license from HyperBranch to market OcuSeal for use in ophthalmology. It will immediately begin to commercialize the product internationally.
Read the full press release...
- HyperBranch Receives CE Mark for OcuSeal™
- Durham, NC, December 20, 2007
HyperBranch Medical Technology, Inc. announced today that it has received a CE Mark for its OcuSeal™ product. OcuSeal liquid ocular bandage provides a protective barrier while stabilizing ocular wounds following surgical or non-surgical trauma and other ocular conditions. OcuSeal is intended for direct application on corneal, conjunctiva, and sclera surfaces to provide a temporary protective barrier in post-surgical, post-traumatic, and non-traumatic ocular conditions The unique, single use device is terminally sterilized and allows for a simple one handed brush application. The CE mark for OcuSeal™ provides regulatory approval for the company to begin sales in Europe and potentially all other countries outside the US.
Read the full press release...
- HyperBranch Selects Amadeus Solution
- Quebec City, December 6, 2005
Amadeus International inc. “Amadeus” (TSX-V: AML), a pioneer and leader of advanced compliance process control solutions, today announced that HyperBranch Medical Technology, Inc., a development-stage medical device company in the ocular surgery market, has selected the Amadeus’ eQCM® compliance process control suite as the foundation for enterprise-wide compliance.
- CED Honors Entrepreneurial Excellence Award Winners
- June 16, 2005
The Council for Entrepreneurial Development (CED) honored area entrepreneurs and high-growth companies during the organization's 19th annual Entrepreneurial Excellence Awards on June 15 at the American Tobacco Historic District in Durham, NC. Over 415 people attended the sold-out celebration.
- HyperBranch Wins Another Award, Sharing CED Technology Honors With Nextreme
- June 15, 2005
HyperBranch Medical Technology, Inc. was selected as one of the winners of the "Technology of the Year". Award at the annual CED Entrepreneurial Excellence Awards. Over 400 people participated in this event.
- HyperBranch Establishes Headquarters in Durham
- Press Release, June 1, 2005
HyperBranch relocates to new headquarters; an efficient and modern laboratory, manufacturing, and office space redeveloped by Alexandria Real Estate Equities, Inc. and located in Durham, North Carolina.
- HyperBranch Closes $6 Million Series A Investment
- Press Release, January 25, 2005
HyperBranch Medical Technology, Inc., a medical device company creating products for the ocular surgery market, today announced it raised $6 million in its first round of venture capital investment. The round was led by The Aurora Funds (Durham, NC) with additional participation from H.I.G. Ventures (Miami, FL).
Read the full press release...